Previous Article | Next Article 
Infection and Immunity, February 2004, p. 1204-1209, Vol. 72, No. 2
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.2.1204-1209.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Haemophilus influenzae Porin Induces Toll-Like Receptor 2-Mediated Cytokine Production in Human Monocytes and Mouse Macrophages
Marilena Galdiero,1 Massimiliano Galdiero,1* Emiliana Finamore,2 Fabio Rossano,1 Maria Gambuzza,3 Maria Rosaria Catania,1 Giuseppe Teti,3 Angelina Midiri,3 and Giuseppe Mancuso3
Dipartimento di Medicina Sperimentale, Sezione di Microbiologia e Microbiologia Clinica,1
Dipartimento di Patologia Generale, Facoltà di Medicina e Chirurgia, Seconda Università degli Studi di Napoli, 80138 Naples,2
Dipartimento di Patologia e Microbiologia Sperimentale, Università degli Studi di Messina, 98125 Messina, Italy3
Received 2 July 2003/
Returned for modification 5 August 2003/
Accepted 28 October 2003

ABSTRACT
The production of proinflammatory cytokines is likely to play
a major pathophysiological role in meningitis and other infections
caused by
Haemophilus influenzae type b (Hib). Previous studies
have shown that Hib porin contributes to signaling of the inflammatory
cascade. We examined here the role of Toll-like receptors (TLRs)
and the TLR-associated adaptor protein MyD88 in Hib porin-induced
production of tumor necrosis factor alpha (TNF-

) and interleukin-6
(IL-6). Hib porin-induced TNF-

and IL-6 production was virtually
eliminated in macrophages from TLR2- or MyD88-deficient mice.
In contrast, macrophages from lipopolysaccharide (LPS)-hyporesponsive
C3H/HeJ mice, which are defective in TLR4 function, responded
normally to Hib porin. Moreover anti-TLR2 antibodies but not
anti-TLR4 antibodies significantly reduced Hib porin-stimulated
TNF-

and IL-6 release from the human monocytic cell line THP-1.
These data indicate that the TLR2/MyD88 pathway plays an essential
role in Hib porin-mediated cytokine production. These findings
may be useful in the development of alternative therapies aimed
at reducing excessive inflammatory responses during Hib infections.

INTRODUCTION
Haemophilus influenzae type b (Hib) is an important cause of
respiratory tract infections and meningitis worldwide, especially
in young children. Although the advent of vaccination programs
has almost eradicated the disease from industrialized countries,
this infection is still present in less-developed areas, where
it remains the leading cause of childhood meningitis (
13). Hib
meningitis is associated with increased cerebrospinal fluid
levels of proinflammatory cytokines, including tumor necrosis
factor alpha (TNF-

) and interleukin-6 (IL-6), which may have
a significant role in the pathophysiology of the disease (
5,
10,
33). TNF-

is a key mediator of proinflammatory responses
contributing significantly both to host defenses and to the
pathophysiology of different infections (
4). IL-6, a pleiotropic
cytokine, acts in conjunction with other mediators to initiate
the early inflammatory response following infection (
4,
16).
Although lipopolysaccharide (LPS) has been clearly documented to play a central role in the pathogenesis of gram-negative infections (6), there is significant evidence that other components of gram-negative bacteria, including porins, also exert important roles (12, 45). Porins are trimeric proteins located in the outer membrane and are largely responsible for the molecular sieve properties of this bilayer (21). The major outer membrane protein (P2) of Hib, with an apparent molecular mass of 37,000 to 40,000 Da, has previously been shown to function as a porin and also as a target for protective antibodies in experimental Hib disease (14). It has been demonstrated that Hib porin contributes to signaling of the inflammatory cascade (10), although the Hib lipooligosaccharide is also likely to play an important role (31).
The recognition of microbial products by the host system is mediated by members of the Toll-like receptor (TLR) family (22). TLRs make up a family of evolutionary conserved pattern recognition molecules that are important signal transducers for the induction of mammalian innate immunity responses, including cytokine responses (1, 18, 29, 30, 39). The best-characterized TLRs to date are TLR2 and TLR4. TLR2 is involved in the recognition of a wide array of bacterial products, including peptidoglycan, lipopeptides, zymosan, and bacterial lipoproteins (2, 3, 7, 24, 42, 43), whereas TLR4 is activated by LPS (19). CD14 acts as a broad-specificity coreceptor that can enhance cell activation induced by TLR4 or TLR2 agonists (35). Engagment of TLRs by microbial products results in homodimerization and recruitment of myeloid differentiation factor-88 (MyD88), an adaptor protein essential for transducing activation signals from TLRs and the IL-1 receptor (20, 40).
The present study investigated the role of TLR2, TLR4, and MyD88 in Hib porin-induced cytokine production. Collectively, our data indicate that the proinflammatory effects of Hib porin are mediated by the TLR2/MyD88 pathway.

Cytokine production in macrophages from genetically defective mice.
The porin was isolated and purified from bacterial cells of
the Hib strain ATTC 9795 using the method described by Nurminen
(
34). Briefly, the bacterial envelopes were treated with Triton
X-100 buffer for 2 h at 37°C in a rotary shaker, dissolved
in sodium dodecyl sulfate (SDS; 4% wt/vol in 0.1 M sodium phosphate,
pH 7.2) buffer, and applied on an Ultragel ACA34 column equilibrated
with 0.25% SDS-sodium azide buffer. Elution flow through the
column was 8 ml/h, and 2 ml was collected. The fraction containing
proteins, identified by measuring absorption at an optical density
of 280 nm, was extensively dialyzed and checked by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) according to the method of Laemmli
(
23). The protein content of the porin preparation was determined
by using the method of Lowry et al. (
25). The purity of the
porin preparation from Hib was checked by SDS-PAGE (Fig.
1)
(
10). The purification protocols and methods used to discount
the likely contamination by LPS of the porin preparation have
been extensively described in previous works (
8,
9). The LPS
contamination was determined by
Limulus amoebocyte lysate assay
(Associates of Cape Cod, Inc.; distributed by PBI International,
Milan, Italy) as described by Yin et al. (
44). The lower detection
limit of this assay was 0.1 EU/ml. The LPS concentration in
each assay preparation was estimated to be about 0.45 EU/ml
compared with that of a standard Hib LPS solution. These contaminating
traces of LPS did not induce any biological activity under our
experimental conditions (data not shown). In some assays, the
LPS activity in the porins was neutralized by adding polymyxin
B (PB) at room temperature for 1 h in a ratio of 1:100 (
32).
To our knowledge, PB interaction with porins has not been described.
In all of the experiments performed, the porins plus PB, in
a concentration range which is nontoxic for the cells, gave
the same results as the porins alone (data not shown), thus
further ruling out any possible activity by LPS contamination.
In addition, PB alone was unable to induce any cell stimulation
(data not shown). In order to ascertain whether TLR2, MyD88,
or TLR4 is involved in cytokine responses to Hib porin, peritoneal
macrophages from TLR2
-/-, MyD88
-/-, and LPS-hyporesponsive mice
were stimulated with increasing doses of Hib porin. MyD88
-/- and TLR2
-/- mice, a kind gift of Shizuo Akira (Osaka, Japan),
were engineered as previously described (
19,
38) on a 129 SV-C57BL/6
background and fivefold backcrossed with C57BL/6 mice. C57BL/6
mice (Charles River Italia, Calco, Italy) served as controls
for the TLR2- and MyD88-deficient mice. C3H/HeJ LPS-hyporesponsive
mice, which have a loss-of-function mutation in TLR4, and control
C3H/HeN mice were also purchased from Charles River. Peritoneal
cells were isolated from the peritoneal cavity by washing with
ice-cold phosphate buffered saline (PBS; 0.01 M phosphate, 0.15
M NaCl, pH 7.2), pelleted by centrifugation, and resuspended
in RPMI 1640 (Invitrogen Life Technologies, San Giuliano Milanese,
Italy) supplemented with 2% fetal calf serum (FCS), 100 IU of
penicillin/ml, and 100 µg of streptomycin/ml. Peritoneal
macrophages were then seeded in 96-well dishes at a density
of 2
x 10
5/well and incubated at 37°C in a 5% humidified
CO
2 environment. After 24 h, nonadherent cells were removed
by washing with medium, and the adherent cells were stimulated
for 22 h with different concentrations of purified Hib porin.
Results were compared with those observed for cells of the respective
control mice suspended in medium alone for spontaneous cytokine
release. Murine TNF-

(mouse TNF-

module set; Bender MedSystems,
Vienna, Austria) and IL-6 murine (IL-6 reagent set, Euroclone,
Wetherby, United Kingdom) concentrations in culture supernatants
were determined using commercial enzyme-linked immunosorbent
assay (ELISA) kits. The lower detection limit of both these
assays was 16 pg/ml of Hib porin-induced dose-dependent TNF-
(Fig.
2, left panels) or IL-6 (Fig.
2, right panels) production
in macrophages from wild-type animals. However, these cytokines
were almost completely absent in TLR2- or MyD88-deficient mice
(Fig.
2). Peritoneal cells derived from C3H/HeJ mice were fully
capable of responding to Hib porin stimulation. These data indicate
that TLR2 and MyD88 but not TLR4 are involved in Hib porin-induced
cytokine production in peritoneal mouse macrophages. Heat treatment
(100°C for 1 h) of the porin preparation completely eliminated
its ability to induce cytokine production in macrophages. This
finding ruled out peptiglycan contamination as a possible cause
of TLR2-dependent cell activation by our porin preparation.

Release of IL-8 by HEK 293-transfected cells.
Human embryonic kidney 293 (HEK 293) cells stably transfected
with TLR2 (HEK 293-TLR2) and TLR4 (HEK 293-TLR4) or cotransfected
with CD14/TLR2 (HEK 293-CD14/TLR2), CD14/TLR4 (HEK 293-CD14/TLR4),
or CD14/TLR4/MD2 (HEK 293-CD14/TLR4/MD2) and HEK 293 cells were
kindly provided by Terje Espevik (Trondheim, Norway). The cells
were maintained in low-glucose Dulbecco's modified Eagle's medium
supplemented with 10% heat-inactivated FCS, HEPES (10 mM),
L-glutamine
(2 µg/ml), penicillin (100 IU/ml), streptomycin (100 µg/ml)
(all obtained from Invitrogen Life Technologies), and puromycin
(1 µg/ml; Sigma Chimica, Milan, Italy). For stimulation
experiments, transfected HEK 293 cells were plated in 24-well
tissue culture plates (5
x 10
5/ml) and incubated for 5 h with
different concentrations of Hib porin and heat-killed
Listeria monocytogenes used as TLR2-dependent positive controls.
L. monocytogenes was obtained from a recent clinical isolate. Bacteria were grown
to the early stationary phase in a chemically defined medium
and were harvested by centrifugation. Killed bacteria were prepared
by heat treatment (80°C for 45 min), followed by extensive
washing with distilled water and lyophilization. The endotoxin
level of the lyophilized bacterial preparation was <0.06
EU/mg, as determined by
Limulus assay (
26). To investigate whether
human TLR2 can also recognize Hib porin, HEK 293 cells transfected
with human TLR2 or TLR4 alone or cotransfected with CD14/TLR2,
CD14/TLR4, and CD14/TLR4/MD2 were incubated with Hib porin (5
µg/ml) or with heat-killed
L. monocytogenes (1 µg/ml).
HEK 293 cells were used as a negative control. Since IL-8 production
is the most widely used marker of HEK 293 cell activation, IL-8
levels were measured in culture supernatants. IL-8 measurement
was performed using a human IL-8 ELISA reagent set (Euroclone).
The lower limit of detection for this assay was <25 pg/ml.
As shown in Fig.
3, Hib porin induced significant IL-8 production
only in CD14/TLR2-transfected cells, suggesting that the coexpression
of CD14 with TLR2 is required by these cells to respond to Hib
porin stimulation.

Effect of MAbs on the release of IL-6 and TNF-

by THP-1 cells stimulated with Hib porin.
To evaluate the involvement of TLR2, TLR4, or CD14 receptors
in Hib porin-induced activation, monoclonal antibodies (MAbs)
which recognize either TLR2, TLR4, or CD14 epitopes were used:
anti-human TLR2 (immunoglobulin G2a [IgG2a], clone TL2.1; Alexis
Biochemicals, Lausen, Switzerland), anti-human TLR4 (IgG1; Alexis
Biochemicals), and anti-human CD14 (IgG2b, clone TIB 228; American
Type Culture Collection, Manassas, Va.). Purified mouse monoclonal
IgG1, IgG2a, or IgG2b (Sigma-Aldrich Srl) used at similar concentrations
of the corresponding MAbs served as isotype controls. Cells
from THP-1 (ATCC TIB-202), a human promyelomonocytic cell line
(
41), were cultured at 37°C in an atmosphere of 5% CO
2 in
complete medium consisting of RPMI 1640 supplemented with 10%
FCS, 2 mM
L-glutamine, 100 IU of penicillin/ml, and 100 µg
of streptomycin/ml. THP-1 cells were subjected to pretreatment
with anti-TLR2 MAb (10 µg/ml), anti-TLR4 mAb (10 µg/ml),
or anti-CD14 MAb (10 µg/ml) and with appropriate nonimmune
isotype controls for 30 min followed by stimulation with Hib
porin at a range of concentrations from 0.05 to 5 µg/ml.
After 24 h, the supernatants were collected and assayed for
the presence of IL-6 and TNF-

. Cell viability was determined
by measuring leakage of lactate dehydrogenase activity from
cells into the supernatant, using a commercial kit (Roche Diagnostic
GmbH; Roche Molecular Biochemicals, Mannheim, Germany). Measurement
of human IL-6 and TNF-

was performed, using human IL-6 and human
TNF-

ELISA reagent sets (Euroclone), respectively. The lower
limits of detection for these assays were 25 and 15 pg/ml, respectively.
As shown in Fig.
4, increased release of IL-6 and TNF-

was observed
in culture supernatants of THP-1 cells stimulated with Hib porin.
IL-6 production was evident with 0.05 µg/ml of porin,
and maximal values were achieved with 5 µg/ml. Anti-TLR4
MAb failed to inhibit IL-6 and TNF-

production induced by Hib
porin at any of the concentrations tested. The addition of anti-TLR2,
however, reduced by 63% and 55%, respectively, IL-6 and TNF-
release from cells stimulated with 5 µg of porins. The
control MAbs, which were used as isotype controls, did not affect
the porin-induced IL-6 and TNF-

production. Moreover, cytokine
production was significantly reduced by the addition of the
anti-CD14 MAb (Fig.
4). These data confirm that TLR2 but not
the TLR4 pathway is involved in Hib porin stimulation of human
monocytic cells.

Discussion.
The host inflammatory response has a major pathophysiological
role in bacterial meningitis. Hib meningitis is associated with
increased cerebrospinal fluid levels of different mediators,
including soluble IL-2 receptor, IL-6, and TNF-

(
33). Moreover,
systemic treatment with anti-IL-6 antibodies attenuated inflammation
in a rat meningitis model (
27), implying a detrimental role
for IL-6. In a previous study, we observed that the Hib porin
may be involved, in conjunction with other bacterial products,
in the pathophysiology of Hib meningitis (
10). In the present
study, we investigated the molecular mechanisms underlying recognition
of Hib porin by host cells.
We focused on TLRs and the TLR-associated adaptor protein MyD88, since recent studies have indicated that recognition of bacterial products in innate immunity responses is often mediated by these molecules (15, 24, 40). The main finding of the present study is that TLR2 is involved in Hib porin-induced cytokine production. In fact, TLR2 or MyD88 deficiency was associated with a virtually complete elimination of TNF-
or IL-6 responses to Hib porin in mice. In contrast, no differences in TNF-
or IL-6 release between C3H/HeJ mice and the wild-type controls were observed after Hib porin stimulation (Fig. 2). Therefore, these results indicated that Hib porin-induced cytokine release in mice was strictly TLR2 and MyD88 dependent but completely TLR4 independent.
The role of human TLR2 in response to Hib porin has been investigated in this work. Stable transfection of HEK 293 cells with TLR2, in conjunction with the costimulatory molecule CD14, conferred responsiveness to Hib porin (Fig. 3). In contrast, transfection with TLR2 alone was not sufficient to induce Hib porin responsiveness. These data suggest that CD14 and TLR2 function together in the recognition of Hib-encoded porin. Data obtained with blocking MAbs further supported this conclusion, as shown by the ability of anti-TLR2 and anti-CD14 antibodies but not anti-TLR4 antibodies to significantly reduce IL-6 release and TNF-
in THP1 cells stimulated with Hib porin.
This finding differs from results obtained using Salmonella porin, which could induce cytokine production in a CD14-independent and CD11a/CD18-dependent fashion (11). Collectively, these data suggest that porins from different bacteria may engage different coreceptors in cell activation phenomena.
To our knowledge, this is the first study to address the role of TLRs in bacterial porin-mediated cytokine production. A recent report by Massari et al. (28) focused on the role of TLRs in the adjuvant effects of neisserial porin P or B. It was found that such adjuvant activity is mediated by surface expression of B7-2 and class 2 major histocompatibility complex on B cells by TLR2-dependent mechanisms. The presence of the adaptor molecule MyD88 was also required. Collectively, our data and those of Massari et al. indicate that porins from different bacteria may be recognized by TLR2. Studies are in progress to ascertain whether enterobacterial and Pseudomonas aeruginosa porins are also capable of activating TLR2.
Further studies are addressing the possibility that porins present as contaminants in LPS preparations may be at least partially responsible for the TLR2-activating properties of such preparations. Indeed, enterobacterial LPS preparations lose their ability to induce TLR2-dependent responses after removal of contaminant proteins (17), which predominantly consist of porins, protein 2, and lipoprotein (37). Shuto et al. (36) have shown that nontypeable H. influenzae strongly activates NF-
B, a transcriptional activator of multiple-host-response genes, by a TLR2-dependent mechanism. Moreover, P6, a conserved outer membrane lipoprotein of all H. influenzae strains, activated NF-
B by a similar mechanism. Future studies are required to assess the relative contribution of porins, lipoproteins, and lipo-oligosaccharide in the overall ability of H. influenzae to stimulate proinflammatory responses.
In conclusion, our data show that Hib porin-induced cytokine production is mediated by the TLR2/MyD88 pathway. These findings may have implications for the development of anti-inflammatory agents to counteract brain and systemic inflammation in the course of serious Hib infections.

ACKNOWLEDGMENTS
We are grateful to Shizuo Akira for providing TLR2- and MyD88-deficient
mice and to Terje Espevik for providing TLR-transfected cell
lines.
This work was performed with the assistance of a grant from the European Commission (HOSPATH contract no. QLK2-CT-2000-00336) and a grant from MIUR of Italy (PRIN project no. 2001061977_002).

FOOTNOTES
* Corresponding author. Mailing address: Dipartimento di Medicina Sperimentale, Sezione di Microbiologia e Microbiologia Clinica, Facoltà di Medicina e Chirurgia, Seconda Università di Napoli, Via De Crecchio 7, 80138 Naples, Italy. Phone: 39 081 5667646. Fax: 39 081 5667578. E-mail:
massimiliano.galdiero{at}unina2.it.

Editor: F. C. Fang

REFERENCES
1 - Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.[CrossRef][Medline]
2 - Aliprantis, A. O., R. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739.[Abstract/Free Full Text]
3 - Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736.[Abstract/Free Full Text]
4 - Cerami, A. 1992. Inflammatory cytokines. Clin. Immunol. Immunopathol. 62:3-10.
5 - Diab, A., J. Zhu, L. Lindquist, B. Wretlind, H. Link, and M. Bakhiet. 1997. Cytokine mRNA profiles during the course of experimental Haemophilus influenzae bacterial meningitis. Clin. Immunol. Immunopathol. 85:236-452.[CrossRef][Medline]
6 - Evans, T. J., E. Strivens, A. Carpenter, and J. Cohen. 1993. Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J. Immunol. 150:5033-5040.[Abstract]
7 - Flo, T. H., O. Halaas, E. Lien, L. Ryan, G. Teti, D. T. Golenbock, A. Sundan, and T. Espevik. 2000. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164:2064-2069.[Abstract/Free Full Text]
8 - Galdiero, F., M. A. Tufano, M. Galdiero, S. Masiello, and M. Di Rosa. 1990. Inflammatory effects of Salmonella typhimurium porins. Infect. Immun. 58:3183-3188.[Abstract/Free Full Text]
9 - Galdiero, M., G. Cipollaro de l'Ero, G. Donnarumma, A. Marcatili, and F. Galdiero. 1995. Interleukin-1 and interleukin-6 gene expression in human monocytes stimulated with Salmonella typhimurium porins. Immunology 86:612-619.[Medline]
10 - Galdiero, M., M. D'Amico, F. Gorga, C. Di Filippo, M. D'Isanto, M. Vitiello, A. Longanella, and A. Tortora. 2001. Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain. Infect. Immun. 69:221-227.[Abstract/Free Full Text]
11 - Galdiero, M., M. D'Isanto, M. Vitiello, E. Finamore, L. Peluso, and M. Galdiero. 2001. Porins from Salmonella enterica serovar Typhimurium induce TNF-
, IL-6 and IL-8 release by CD14-independent and CD11a/CD18-dependent mechanisms. Microbiology 147:2697-2704.[Abstract/Free Full Text]
12 - Galdiero, M., M. Vitiello, E. Sanzari, M. D'Isanto, A. Tortora, A. Longanella, and S. Galdiero. 2002. Porins from Salmonella enterica serovar Typhimurium activate the transcription factors activating protein 1 and NF-
B through the Raf-1-mitogen-activated protein kinase cascade. Infect. Immun. 70:558-568.[Abstract/Free Full Text]
13 - Gessner, B. D. 2002. Worldwide variation in the incidence of Haemophilus influenzae type B meningitis and its association with ampicillin resistance. Eur. J. Clin. Microbiol. Infect. Dis. 21:79-87.[CrossRef][Medline]
14 - Hansen, E. J., F. R. Gonzales, N. R. Chamberlain, M. V. Norgard, E. E. Miller, L. D. Cope, S. E. Pelzel, B. Gaddy, and A. Clausell. 1988. Cloning of the gene encoding the major outer membrane protein of Haemophilus influenzae type b. Infect. Immun. 56:2709-2716.[Abstract/Free Full Text]
15 - Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.[CrossRef][Medline]
16 - Hirano, T. 1992. Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 62:60-65.
17 - Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Repurification of lipopolysaccaride eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165:618-622.[Abstract/Free Full Text]
18 - Horng, T., G. M. Barton, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-841.[CrossRef][Medline]
19 - Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.[Abstract/Free Full Text]
20 - Janssens, S., and R. Beyaert. 2002. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27:474-482.[CrossRef][Medline]
21 - Jeanteur, D., J. H. Lakey, and F. Pattus. 1991. The bacterial porin superfamily: sequence alignment and structure prediction. Mol. Microbiol. 5:2153-2164.[CrossRef][Medline]
22 - Kopp, E. B., and R. Medzhitov. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.[CrossRef][Medline]
23 - Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 277:680-685.
24 - Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425.[Abstract/Free Full Text]
25 - Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1985. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275.
26 - Mancuso, G., A. Midiri, C. Beninati, G. Piraino, A. Valenti, G. Nicocia, D. Teti, J. Cook, and G. Teti. 2002. Mitogen-activated protein kinases and NF-
B are involved in TNF-
responses to group B streptococci. J. Immunol. 169:1401-1409.[Abstract/Free Full Text]
27 - Marby D, G. R. Lockhart, R. Raymond, and J. G Linakis. 2001. Anti-interleukin-6 antibodies attenuate inflammation in a rat meningitis model. Acad. Emerg. Med. 8:946-949.[Medline]
28 - Massari, P., P. Henneke, Y. Ho., E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:1533-1537.[Abstract/Free Full Text]
29 - Medzhitov, R., and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.[CrossRef][Medline]
30 - Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.[CrossRef][Medline]
31 - Miyazaki, S., T. Nunoya, T. Matsumoto, N. Furuya, K. Tateda, and K. Yamaguchi. 2001. Lipoolygosaccharide indirectly enhances inflammatory lesions in lungs as a primary infection site by non-encapsulated and type B Haemophilus influenzae through production of cytokines. Cytokine 15:171-174.[CrossRef][Medline]
32 - Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to a lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.[CrossRef][Medline]
33 - Nishimura, M., H. Tsukahara, M. Hiraoka, Y. Osaka, Y. Ohshima, A. Tanizawa, and M. Mayumi. 2000. Systemic inflammatory response syndrome and acute renal failure associated with Haemophilus influenzae septic meningitis. Am. J. Nephrol. 20:208-211.[CrossRef][Medline]
34 - Nurminen, M. 1985. Isolation of porin trimers. Enterobacterial surface antigen methods for molecular characterization, p. 294. In T. K. Korhonen, E. A. Dawes, and P. H. Makela (ed.), FEMS Symposium 25. Elsevier Science Publishers BV, Amsterdam, The Netherlands.
35 - Opal, M. S., and C. E. Huber. 2002. Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit. Care 6:125-136.[CrossRef][Medline]
36 - Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-
B by nontypeable Haemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKK
/ß-I
B
and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98:8774-8779.[Abstract/Free Full Text]
37 - Sultzer, B. M., and G. W. Goodman. 1976. Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes. J. Exp. Med. 144:821-830.[Abstract/Free Full Text]
38 - Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.[CrossRef][Medline]
39 - Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59-65.[CrossRef][Medline]
40 - Takeuchi, O., and S. Akira. 2002. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr. Top. Microbiol. Immunol. 270:155-167.[Medline]
41 - Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukaemia cell line (THP-1). Int. J. Cancer 26:171-175.[Medline]
42 - Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815.[CrossRef][Medline]
43 - Underhill, D. M., A. Ozinsky, K. D. Smith, and A. Aderem. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459-14463.[Abstract/Free Full Text]
44 - Yin, E. T., C. Galanos, S. Kinsky, R. A. Bradshow, S. Wessler, O. Luderitz, and M. F. Sarmiento. 1972. Picogram-sensitive assay for endotoxin: gelatin of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from gram-negative bacteria. Biochim. Biophys. Acta 261:284-289.[Medline]
45 - Zhang, H., D. W. Nielsen, J. W. Peterson, and G. R. Klimpel. 1998. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66:5196-5201.[Abstract/Free Full Text]
Infection and Immunity, February 2004, p. 1204-1209, Vol. 72, No. 2
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.2.1204-1209.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pang, B., Winn, D., Johnson, R., Hong, W., West-Barnette, S., Kock, N., Swords, W. E.
(2008). Lipooligosaccharides Containing Phosphorylcholine Delay Pulmonary Clearance of Nontypeable Haemophilus influenzae. Infect. Immun.
76: 2037-2043
[Abstract]
[Full Text]
-
Moon, S. K., Woo, J.-I., Lee, H.-Y., Park, R., Shimada, J., Pan, H., Gellibolian, R., Lim, D. J.
(2007). Toll-Like Receptor 2-Dependent NF-{kappa}B Activation Is Involved in Nontypeable Haemophilus influenzae-Induced Monocyte Chemotactic Protein 1 Up-Regulation in the Spiral Ligament Fibrocytes of the Inner Ear. Infect. Immun.
75: 3361-3372
[Abstract]
[Full Text]
-
Mogensen, T. H., Paludan, S. R., Kilian, M., Ostergaard, L.
(2006). Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol.
80: 267-277
[Abstract]
[Full Text]
-
Andersen, J. M., Al-Khairy, D., Ingalls, R. R.
(2006). Innate Immunity at the Mucosal Surface: Role of Toll-Like Receptor 3 and Toll-Like Receptor 9 in Cervical Epithelial Cell Responses to Microbial Pathogens. Biol. Reprod.
74: 824-831
[Abstract]
[Full Text]
-
O'Connell, C. M., Ionova, I. A., Quayle, A. J., Visintin, A., Ingalls, R. R.
(2006). Localization of TLR2 and MyD88 to Chlamydia trachomatis Inclusions: EVIDENCE FOR SIGNALING BY INTRACELLULAR TLR2 DURING INFECTION WITH AN OBLIGATE INTRACELLULAR PATHOGEN. J. Biol. Chem.
281: 1652-1659
[Abstract]
[Full Text]
-
Wieland, C. W., Florquin, S., Maris, N. A., Hoebe, K., Beutler, B., Takeda, K., Akira, S., van der Poll, T.
(2005). The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung. J. Immunol.
175: 6042-6049
[Abstract]
[Full Text]
-
Ramphal, R., Balloy, V., Huerre, M., Si-Tahar, M., Chignard, M.
(2005). TLRs 2 and 4 Are Not Involved in Hypersusceptibility to Acute Pseudomonas aeruginosa Lung Infections. J. Immunol.
175: 3927-3934
[Abstract]
[Full Text]
-
Berenson, C. S., Murphy, T. F., Wrona, C. T., Sethi, S.
(2005). Outer Membrane Protein P6 of Nontypeable Haemophilus influenzae Is a Potent and Selective Inducer of Human Macrophage Proinflammatory Cytokines. Infect. Immun.
73: 2728-2735
[Abstract]
[Full Text]
-
Ratner, A. J., Lysenko, E. S., Paul, M. N., Weiser, J. N.
(2005). Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl. Acad. Sci. USA
102: 3429-3434
[Abstract]
[Full Text]